4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Our aim was to investigate the impact of intravenous (IV) beta-blocker therapy on short-term mortality and other in-hospital events in patients with ST-segment elevation myocardial infarction (STEMI) treated with dual antiplatelet therapy (DAPT) and primary percutaneous coronary intervention (PCI).

          Related collections

          Author and article information

          Journal
          EuroIntervention
          EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
          Europa Digital & Publishing
          1969-6213
          1774-024X
          Jun 02 2017
          : 13
          : 2
          Affiliations
          [1 ] Department of Cardiology, Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden.
          Article
          EIJ-D-16-01021
          10.4244/EIJ-D-16-01021
          28242589
          f2eefca5-31da-492e-941e-e1e911303f2c
          History

          Comments

          Comment on this article